VANCOUVER, BC, Feb. 28, 2022 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI)(OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders (the “Meeting”), held earlier today. A total of 26,215…


Previous articleField Trip Health and Cerebral Partner to Provide End-to-End Mental Health Care
Next articleThe Need for an International Psychedelic Religious Survey